Praxis of Otorhinolaryngology

Ali Bayram1, Nuri Ünsal1, Aycan Şahin Genç1, Mehmet Yaşar1, Fatma Şenel2

1Kayseri Şehir Eğitim ve Araştırma Hastanesi, Kulak Burun Boğaz Kliniği, Kayseri, Türkiye
2Kayseri Şehir Eğitim ve Araştırma Hastanesi, Patoloji Bölümü, Kayseri, Türkiye

Keywords: Frozen section, lymphadenopathy, neck, parotid neoplasms.

Abstract

OBJECTIVE: This study aims to report the frozen section examination (FSE) results of level 2 lymph nodes (LNs) during parotidectomies for parotid masses preoperatively diagnosed as a benign lesion and to evaluate the possible role of FSE in the diagnosis and treatment plan of these patients.

METHODS: The prospective study was conducted on patients who underwent parotidectomy with a preliminary diagnosis of a benign parotid lesion between May 2018 and June 2023. Among 120 patients who underwent parotidectomy, 30 patients (24.79%; 23 males, 7 females; mean age: 53.3±12.3 years; range, 22 to 79 years) who had FSE examination of level 2 LNs during parotidectomy were identified. The age, sex, fine-needle aspiration biopsy (FNAB), FSE, and final histopathology reports were evaluated from the patient records. All parotidectomies were performed by the same surgeon using the modified Blair incision, and level 2 LNs were harvested to ascertain the histopathological content through FSE during the surgery.

RESULTS: Twenty-five (83.3%) of the 30 patients had a preoperative FNAB, and it was compatible with the final histopathology in 20 (66.67%) patients. The most common parotid lesions were Warthin’s tumor (60%) and pleomorphic adenoma (36.67%), respectively. The FSE of all LNs was reported as reactive, and FSE did not alter the treatment plan in any patient.

CONCLUSION: An LN metastasis detected with FSE may be utilized as an adjunctive diagnostic tool during parotidectomy to prevent the preoperative misdiagnosis of a high-grade malignancy as a benign parotid gland lesion. Although the present study did not demonstrate such a contribution to a false-negative preoperative diagnosis of primary malignancy, the absence of a metastatic LN disease may be an auxiliary finding to confirm the diagnosis of a benign gland disease.